PRM34 - Cost –Effectiveness of Obinutuzumab As Frontline Treatment For Unfit Patients With Chronic Lymphocytic Leukemia In Republic of Macedonia

Saved in:

Bibliographic Details
Published in	Value in health Vol. 20; no. 9; p. A736
Main Authors	Kapedanovska Nestorovska, A, Sterjev, Z, Naumovska, Z, Grozdanova, A, Dimovski, A, Suturkova, L
Format	Journal Article
Language	English
Published	Elsevier Inc 01.10.2017
Online Access	Get full text

Loading…

More Information
ISSN:	1098-3015 1524-4733
DOI:	10.1016/j.jval.2017.08.2020